Hints and tips:
Related Special Reports
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
...The Development Bank of Japan said it wanted to connect the country’s start-ups with others across the world....
...[Enlarge] Further reading:— Alert: Alphaville LLC issues new research report on Duchy of Cornwall (FTAV)— Greenland: Alphaville put on its sellside hat for the deal of the century (FTAV)— Alphaville LLC...
...Claire Kumar Senior Research Fellow, ODI (Formerly Overseas Development Institute), Bangor, County Down, UK...
...It has pledged to double funding for dementia research to £160mn a year by 2025....
...other drug development....
...Jodie Keane Senior Research Fellow ODI (Formerly Overseas Development Institute), London SE1, UK...
...Dr Matthew Hobbs, director of research at Prostate Cancer UK, said such changes had “made the process safer and more accurate” but better evidence was needed to understand their full impact....
...One of his most well-known contributions to research is the ‘Sally-Anne task’....
...charity’s research information manager....
...The role of Einstein’s general theory of relativity in the development of the Global Positioning System that had revolutionised navigation was a “great example”, he said....
...In 2022/23, NIHR research expenditure for all cancers was £121.8mn.”...
...“There is an issue of duplication, where too many funds seem to be chasing similar prospects . . . without co-ordinating their investments,” said Bright Simons, vice-president of research at Ghanaian think-tank...
...Developing new antibiotics is often unattractive for pharmaceutical companies, as research and development costs are high but their use is designed to be limited to reduce the risk of the product driving...
...Research published this month by the African Private Capital Association (Avca), an industry body, showed there were 450 private capital deals last year in Africa with a combined value of $5.9bn — the biggest...
...Citadel, which manages roughly $61bn, made a record $16bn in profit for investors in 2022, according to research from LCH Investments....
...The plans by the self-made billionaire, who has openly tied his business interests to India’s development goals, complement Prime Minister Narendra Modi’s desire to position his country as a leader and voice...
...Since the third quarter of 2023 when it had 82 new drugs in development, the company has jettisoned 16 drugs and added 12 others, including the weight-loss drug it gained through its $3.1bn acquisition of...
...not involved in the research....
...The results from the research, which involved 156 people, were a “major breakthrough”, said Olivier Rascol, a Toulouse University Hospital professor and a co-author of the research with Prof Wassilios Meissner...
...Science and Scopus — as well as researchers at St Joseph’s University and elsewhere, have, in recent years, developed ways to automatically determine the relevance of journal articles to the UN Sustainable Development...
...Gathering more than 600 studies in development economics, she found less than 10 per cent mentioned a policy’s costs. (Policymakers care about prices.)...
Food and Drug Administration poised to call for outside assessment of Lykos PTSD therapy in test for psychedelics sector
...According to a European Commission analysis of the world’s 2,500 highest spending companies in research and development published in 2023, 12 per cent of leading companies investing in health research are...
...A dearth of career scientists and public funding risks undermining efforts to use technological breakthroughs to tackle the biggest health threats, the head of a leading international research organisation...
International Edition